Document is current

Any future updates will be listed below

Ibrutinib: new option for relapsed MZL

Crossref DOI link: https://doi.org/10.1038/nrclinonc.2017.26

Published Online: 2017-03-20

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark